Licensed vaccine product
Gardasil 9: side effects, ingredients & package insert
Merck Sharp & Dohme LLC · HPV vaccine · vlp · intramuscular · 0.5 mL
Gardasil 9 ingredients (FDA package insert, Section 11)
Per-dose composition as stated in the prescribing information; verified 2026-07-09. Click an ingredient for every vaccine that contains it.
| Role | Ingredient | Amount per dose |
|---|---|---|
| Antigen | HPV Type 6 L1 protein | ≈30 mcg |
| Antigen | HPV Type 11 L1 protein | ≈40 mcg |
| Antigen | HPV Type 16 L1 protein | ≈60 mcg |
| Antigen | HPV Type 18 L1 protein | ≈40 mcg |
| Antigen | HPV Type 31 L1 protein | ≈20 mcg |
| Antigen | HPV Type 33 L1 protein | ≈20 mcg |
| Antigen | HPV Type 45 L1 protein | ≈20 mcg |
| Antigen | HPV Type 52 L1 protein | ≈20 mcg |
| Antigen | HPV Type 58 L1 protein | ≈20 mcg |
| Adjuvant | Amorphous aluminum hydroxyphosphate sulfate (AAHS) | |
| Preservative | None (preservative-free) | Single-dose presentation; label states no preservative. |
| buffer | Sodium chloride | 9.56 mg |
| buffer | L-histidine | 0.78 mg |
| surfactant | Polysorbate 80 | 50 mcg |
| buffer | Sodium borate | 35 mcg |
| culture_medium_residual | Yeast protein | trace residual (<7 mcg/dose in related labeling) |
| diluent | Water for injection | q.s. |
Source: FDA package insert. Formulations change — re-verify before clinical use.
Gardasil 9 side effects: where the data is
Reported reactions for Gardasil 9 and the other HPV products are compiled on the HPV vaccine page: pre-licensure trial reactogenicity, VAERS report counts, and international databases (Canada Vigilance, EudraVigilance, Lareb, VigiAccess). Those counts are spontaneous reports with no denominator — a report does not establish that the vaccine caused the event.
Gardasil 9 lot number lookup
VAERS report counts are available by lot for HPV vaccines. Use the HPV lot number lookup or search any lot directly in the lot explorer. Lot numbers are printed on the vaccination record card and the vial label.
Schedule and age range
Licensed ages and the recommended series for HPV vaccines are on the HPV vaccine page; how 31 countries schedule it is on HPV schedule by country. Always confirm the product-specific age range in the current package insert.
Common questions about Gardasil 9
What are the side effects of Gardasil 9?
Common reactions listed in the Gardasil 9 package insert are injection-site pain, redness or swelling and short-lived systemic symptoms such as fever, tiredness or irritability. Rarer events and the reported counts from VAERS and international databases are on the HPV vaccine page; counts are reports, not rates, and do not prove the vaccine caused the event.
What is in Gardasil 9?
Gardasil 9 contains HPV Type 6 L1 protein; HPV Type 11 L1 protein; HPV Type 16 L1 protein; HPV Type 18 L1 protein; HPV Type 31 L1 protein; HPV Type 33 L1 protein; HPV Type 45 L1 protein; HPV Type 52 L1 protein; HPV Type 58 L1 protein as antigen; adjuvant: Amorphous aluminum hydroxyphosphate sulfate (AAHS); it is preservative-free. Excipients: Sodium chloride, L-histidine, Polysorbate 80, Sodium borate, Yeast protein, Water for injection. Amounts per dose are in the table above, taken from Section 11 of the FDA package insert (verified 2026-07-09).
Where is the Gardasil 9 package insert?
The FDA-licensed prescribing information for Gardasil 9 is published by Merck Sharp & Dohme LLC and the FDA; the source used for this page is https://www.fda.gov/vaccines-blood-biologics/vaccines/gardasil-9. Formulations change, so re-verify the current insert before clinical use.
Reviewed 2026-10-08 · Matthew Thomas J Halma, Founder, Open Source Medicine Foundation. Informational, not medical advice.